HCA Healthcare, Inc. HCA
NYSE · Healthcare · Medical - Care Facilities
$475.57
Close on Fri, 20 Nov 2026 · market value $99.3B
What the price is betting on
In line with its recordAt $476, the price assumes revenue grows about 4% a year for five years, from $78.7B to about $93.1B by FY2030. That is about the same as what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 9.4% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than HCA? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$430
Base
$481
Bull
$537
Today $476
- Bear $430. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $481. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $537. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$79.5B$79.2B, on the path
- FY2027$82.7B$81.6B, on the path
- FY2028$86B$85.4B, on the path
- FY2029$89.5B$90.4B, on the path
- FY2030$93.1B$95.1B, on the path
Each year's revenue at 4% growth from $78.7B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Care Facilities · listed on NYSE
- Revenue, FY2025
- $75.6B
- Growth, 3 years a year
- 7.2%
- Cash margin
- 10%
- Net debt
- $49.2B
- Shares, 3-year change
- −19%
- Dividend yield
- 0.7%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.